HIV-Related Stigma Intervention for Malaysian Clinicians

Hiv Clinical Trial

Official title:

Implementing Stigma Reduction Tools Via a Popular Teletraining Platform to Reduce Clinician Stigma and Disparities in HIV Testing, Prevention, and Linkage to Care in Malaysia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05597787
• Other study ID #: R34MH124390
• Status: Completed
• Phase: N/A
• Start date: July 26, 2022
• Est. completion date: May 11, 2023

Study information

• Verified date: January 2024
• Source: University of Delaware
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: May 11, 2023
• Est. primary completion date: March 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• practicing general practitioner or family medicine specialist in Malaysia

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Hiv

Intervention

Behavioral:
• HIV Connect
online education and clinical skills
• Project ECHO for HIV Prevention
education and clinical skills
• Project ECHO for HIV Prevention and Stigma Reduction
education, clinical skills and contact

Locations

Country	Name	City	State
Malaysia	University of Malaya	Kuala Lumpur

Sponsors (2)

Lead Sponsor	Collaborator
University of Delaware	University of Malaya

Country where clinical trial is conducted

Malaysia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acceptability of Intervention	Measured with Acceptability of Intervention Measure. Average scores range 1-5, with higher scores indicating greater acceptability.	Month 9 Assessment
Primary	Feasibility of Intervention	Measured with Feasibility of Intervention Measure. Average scores range 1-5, with higher scores indicating greater feasibility.	Month 9 Assessment
Primary	Stigma Reduction: Prejudice	Measured with Feelings Thermometers. Positive/Negative affect is measured on 0-100 point scale, with higher scores indicating more prejudice.	Month 9 Assessment
Primary	Stigma Reduction: Stereotypes	Measured with subscale of Multidimensional HIV-Related Stigma Scale. Average scores range 1-5, with higher scores indicating greater stereotypes.	Month 9 Assessment
Primary	Stigma Reduction: Discrimination	Measured with subscale of Multidimensional HIV-Related Stigma Scale Average scores range 1-5, with higher scores indicating greater discrimination.	Month 9 Assessment
Secondary	HIV Prevention Procedures: HIV Testing	Measured with weekly diary of HIV tests performed. Number of HIV tests will be summed over duration of intervention.	Cumulative over 9 month intervention
Secondary	HIV Prevention Procedures: PrEP Prescriptions	Measured with weekly diary of PrEP prescriptions. Number of PrEP prescriptions will be summed over duration of intervention.	Cumulative over 9 month intervention